Stock AMED AMEDISYS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Amedisys, Inc.

Equities

AMED

US0234361089

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
91.79 USD +0.69% Intraday chart for Amedisys, Inc. +1.54% -3.44%
Apr. 24 Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 MT
Apr. 24 Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,384 9,624 5,278 2,714 3,102 2,999 - -
Enterprise Value (EV) 1 5,596 9,758 5,680 3,095 3,361 3,304 3,310 2,999
P/E ratio 43.5 x 53.1 x 25.5 x 23 x -317 x 25.9 x 19.7 x 20.3 x
Yield - - - - - - - -
Capitalization / Revenue 2.75 x 4.65 x 2.38 x 1.22 x 1.39 x 1.29 x 1.2 x 1.14 x
EV / Revenue 2.86 x 4.71 x 2.57 x 1.39 x 1.5 x 1.42 x 1.33 x 1.14 x
EV / EBITDA 24.8 x 35.7 x 19 x 11.8 x 13.6 x 13.1 x 12.1 x -
EV / FCF 28.8 x 35 x 31.1 x 24.3 x 25.5 x 27.3 x 19.8 x -
FCF Yield 3.47% 2.86% 3.21% 4.11% 3.91% 3.66% 5.06% -
Price to Book 8.41 x 11.9 x 5.65 x 2.58 x 2.91 x 2.32 x 2.05 x -
Nbr of stocks (in thousands) 32,255 32,811 32,602 32,492 32,633 32,677 - -
Reference price 2 166.9 293.3 161.9 83.54 95.06 91.79 91.79 91.79
Announcement Date 2/18/20 2/24/21 2/23/22 2/15/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,956 2,072 2,214 2,223 2,236 2,328 2,495 2,626
EBITDA 1 225.3 273.5 299.6 262.1 247 252.2 272.9 -
EBIT 1 206.9 244.7 268.7 237.1 223.2 228.1 248.4 -
Operating Margin 10.58% 11.81% 12.14% 10.67% 9.98% 9.8% 9.96% -
Earnings before Tax (EBT) 1 170.4 210.8 280.2 160.2 39.62 168.6 215.5 -
Net income 1 126.8 183.6 209.1 118.6 -9.747 117.7 155.7 159.3
Net margin 6.49% 8.86% 9.44% 5.34% -0.44% 5.06% 6.24% 6.07%
EPS 2 3.840 5.520 6.340 3.630 -0.3000 3.545 4.670 4.530
Free Cash Flow 1 194.1 279.2 182.6 127.1 131.6 121 167.6 -
FCF margin 9.93% 13.48% 8.25% 5.72% 5.88% 5.2% 6.72% -
FCF Conversion (EBITDA) 86.16% 102.06% 60.95% 48.51% 53.26% 47.97% 61.4% -
FCF Conversion (Net income) 153.05% 152.05% 87.33% 107.17% - 102.79% 107.65% -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/18/20 2/24/21 2/23/22 2/15/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 559.3 545.3 557.9 558 562.1 556.4 553 556.2 570.8 571.4 575.1 582.9 596.5 614.4 628.1
EBITDA 1 64.81 66.31 74.35 61.51 59.89 57.84 74.64 57.88 56.65 59.86 63.47 63.82 66.49 62.06 70.72
EBIT 1 55.67 58.3 68.13 56.03 54.66 52.14 68.44 51.82 50.76 53.72 57.5 58.62 58.2 54.24 64.44
Operating Margin 9.95% 10.69% 12.21% 10.04% 9.72% 9.37% 12.38% 9.32% 8.89% 9.4% 10% 10.06% 9.76% 8.83% 10.26%
Earnings before Tax (EBT) 1 46.88 43.73 40.36 34.82 41.34 34.71 -62.23 37.95 29.2 27.23 39.98 42.49 42.87 48.46 56.15
Net income 1 34.05 31.67 29.58 25.64 31.72 25.25 -80.28 25.96 19.32 14.4 34.74 35.73 36.58 35.44 41.25
Net margin 6.09% 5.81% 5.3% 4.6% 5.64% 4.54% -14.52% 4.67% 3.39% 2.52% 6.04% 6.13% 6.13% 5.77% 6.57%
EPS 2 1.040 0.9700 0.9100 0.7900 0.9700 0.7700 -2.460 0.7900 0.5900 0.4400 1.010 1.045 1.050 1.062 1.238
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/23/22 4/27/22 7/27/22 10/26/22 2/15/23 5/3/23 7/26/23 10/24/23 2/21/24 4/24/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 212 133 402 381 259 305 311 -
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.9405 x 0.487 x 1.343 x 1.453 x 1.05 x 1.208 x 1.139 x -
Free Cash Flow 1 194 279 183 127 132 121 168 -
ROE (net income / shareholders' equity) 25.9% 28.1% 22.5% 16.5% 13.3% 13% 13.3% -
ROA (Net income/ Total Assets) 14.7% 14.4% 11.5% 8.53% 6.97% 7.13% 8.12% -
Assets 1 864.5 1,278 1,825 1,391 -139.9 1,650 1,918 -
Book Value Per Share 2 19.80 24.70 28.60 32.30 32.60 39.60 44.70 -
Cash Flow per Share 2 6.120 8.690 5.730 4.080 4.210 5.070 6.960 -
Capex 1 7.89 5.33 6.3 6.17 5.62 7.51 7.3 -
Capex / Sales 0.4% 0.26% 0.28% 0.28% 0.25% 0.32% 0.29% -
Announcement Date 2/18/20 2/24/21 2/23/22 2/15/23 2/21/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Amedisys, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
91.79 USD
Average target price
97.78 USD
Spread / Average Target
+6.52%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Home Healthcare Services

1st Jan change Capi.
AMEDISYS, INC. Stock Amedisys, Inc.
-3.44% 3B
BRIGHTSPRING HEALTH SERVICES, INC. Stock BrightSpring Health Services, Inc.
0.00% 1.81B
THE PENNANT GROUP, INC. Stock The Pennant Group, Inc.
+49.28% 624M
ENHABIT, INC. Stock Enhabit, Inc.
-3.09% 503M
DOCGO INC. Stock DocGo Inc.
-35.42% 368M
BASTIDE LE CONFORT MÉDICAL Stock Bastide Le Confort Médical
-34.25% 139M
SAINT-CARE HOLDING CORPORATION Stock Saint-Care Holding Corporation
-13.04% 136M
KATO (HONG KONG) HOLDINGS LIMITED Stock Kato (Hong Kong) Holdings Limited
+1.92% 67.7M
Home Healthcare Services
  1. Stock Market
  2. Equities
  3. AMED Stock
  4. Financials Amedisys, Inc.